Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425228 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL10511364 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL30655986 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL29009630 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL524648 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL31006936 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL2510639 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL6384699 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL702670 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL2693783 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404533-B2 | Bioconjugate vaccines' synthesis in prokaryotic cell lysates | NORTHWESTERN UNIVERSITY (US) | 2025-09-02 | — | — | US | disclosed |
| US-12365930-B2 | Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates | NORTHWESTERN UNIVERSITY (US) | 2025-07-22 | — | — | US | disclosed |
| US-20240277824-A1 | BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-08-22 | — | — | US | disclosed |
| US-20230279460-A1 | METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES | NORTHWESTERN UNIVERSITY | 2023-09-07 | — | — | US | disclosed |
| US-20230212633-A1 | COMPOSITIONS AND METHODS FOR RAPID IN VITRO SYNTHESIS OF BIOCONJUGATE VACCINES IN VITRO VIA PRODUCTION AND N-GLYCOSYLATION OF PROTEIN CARRIERS IN DETOXIFIED PROKARYOTIC CELL LYSATES | CORNELL UNIVERSITY | 2023-07-06 | — | — | US | disclosed |
| CN-116171328-A | Method for producing purified mixtures of different oligosaccharides produced by cell culture or microbial fermentation | 因比奥斯公司 | 2023-05-26 | — | — | CN | disclosed |
| US-11542538-B2 | Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates | CORNELL UNIVERSITY (US) | 2023-01-03 | — | — | US | disclosed |
| US-11530432-B2 | Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates | NORTHWESTERN UNIVERSITY (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220267821-A1 | BIOCONJUGATE VACCINES' SYNTHESIS IN PROKARYOTIC CELL LYSATES | CORNELL UNIVERSITY | 2022-08-25 | — | — | US | disclosed |
| EP-3908669-A1 | BIOCONJUGATE VACCINES' SYNTHESIS IN PROKARYOTIC CELL LYSATES | Northwestern University (US) | 2021-11-17 | — | — | EP | disclosed |
| WO-2007035897-A2 | IMPROVED LIVE ATTENUATED VACCINE STRAIN FOR PREVENTION OF TULAREMIA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-03-29 | — | — | WO | disclosed |
| EP-1509607-A1 | IMMUNOGENIC SEQUENCES | The Secretary of State for Defence (GB) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003102191-A1 | IMMUNOGENIC SEQUENCES | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2003-12-11 | — | — | WO | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277824-A1 | BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS | OSTC, DDOST, NGLY1 | PAX8 2301/4885ALDH1A1 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.